Steffen Wad Jørgensen
Plus aucun poste en cours
Profil
Steffen Wad Jørgensen worked as the Chief Development Officer at RhoVac AB.
Anciens postes connus de Steffen Wad Jørgensen
| Sociétés | Poste | Fin |
|---|---|---|
| CHOSA ONCOLOGY AB | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
RhoVac AB
 RhoVac AB BiotechnologyHealth Technology RhoVac AB opertaes as biotechnology company that engages in the research and development of immunotherapy. The firm develops therapeutic cancer vaccines. Its main focus is the development of a drug with the potential to prevent or limit the metastasis of metastatic cancers. The company was founded by Bo Anders Ljungqvist, Per Thor Straten, and Mads Hald Andersen in November 2015 and is headquartered in Lund, Sweden. | Health Technology |
